To further investigate the role of TGF-β signaling pathway in human HCCs, we evaluated expression of several TGF-β signaling pathway components including TβRI, TβRII, and Smad4 in five HCC cell lines which have shown different TGF-β responsive characteristics [27]. Here, SMAD4 is linked to hepatocellular carcinoma.